The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Inhibition of Early Atherogenesis by Losartan in Monkeys With Diet-Induced Hypercholesterolemia
Abstract
Background —Angiotensin II may contribute to atherogenesis by facilitating the proliferative and inflammatory response to hypercholesterolemia. This study determined, in a primate model of diet-induced atherosclerosis, the effect of AT 1 blockade on fatty-streak formation, plasma lipids, and surrogate markers of vascular injury. Methods and Results —Male cynomolgus monkeys fed a diet containing 0.067 mg cholesterol/kJ for 20 weeks were given losartan (180 mg/d, n=6) or vehicle (n=8) for 6 weeks starting at week 12 of the dietary regimen. Arterial pressure, heart rate, plasma total and lipoprotein cholesterol concentrations, and lipoprotein particle sizes and subclass distributions were unaffected by treatment. Losartan caused significant ( P <0.05) increases in plasma angiotensin II and angiotensin-(1–7). Compared with vehicle-treated controls, losartan reduced the extent of fatty streak in the aorta, the coronary arteries, and the carotid arteries by ≈50% ( P <0.05). A significant ( P <0.05) reduction in the susceptibility of LDL to in vitro oxidation, serum levels of monocyte chemoattractant protein-1, and circulating monocyte CD11b expression were also associated with losartan treatment. In addition, serum levels of vascular cell adhesion molecule-1 and E-selectin did not change during treatment but increased after discontinuation of losartan. Serum C-reactive protein, platelet aggregability, and white cell counts were not modified by losartan. Conclusions —This study demonstrates for the first time an antiatherogenic effect of AT 1 receptor blockade in nonhuman primates. Losartan inhibited fatty-streak formation through mechanisms that may include protection of LDL from oxidation and suppression of vascular monocyte activation and recruitment factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Continuous Monitoring of in Vztro Oxidation of Human Low Density Lipoprotein
Esterbauer, H., Striegl, G., Puhl, H., & Rotheneder, M. (1989) · Free Radical Research Communications · doi:10.3109/10715768909073429 · Cited by 1,790
Inhibition of oxidation of methyl linoleate in solution by vitamin E and vitamin C.
Niki, E., Saito, T., Kawakami, A., & Kamiya, Y. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43026-2 · Cited by 579
Weber, C., Erl, W., Weber, K. S. C., & Weber, P. C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00324-0 · Cited by 411
Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.
Chobanian, A. V., Haudenschild, C. C., Nickerson, C., & Drago, R. (1990) · Hypertension · doi:10.1161/01.hyp.15.3.327 · Cited by 411
Freedman, D. S., Otvos, J. D., Jeyarajah, E. J., Barboriak, J. J., Anderson, A. J., & Walker, J. A. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.7.1046 · Cited by 345
Angiotensin-(1–7) Reduces Smooth Muscle Growth After Vascular Injury
Strawn, W. B., Ferrario, C. M., & Tallant, E. A. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.207 · Cited by 184
Self-citationClozel, M., Kuhn, H., Hefti, F., & Baumgartner, H. R. (1991) · Hypertension · doi:10.1161/01.hyp.18.2.132 · Cited by 167
Masuda, J., & Ross, R. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.2.164 · Cited by 167
Angiotensin(1–7) in the spontaneously hypertensive rat
Kohara, K., Brosnihan, K. B., & Ferrario, C. M. (1993) · Peptides · doi:10.1016/0196-9781(93)90063-m · Cited by 152
Self-citation
Cited by
Inflammation and angiotensin II
Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., & Egido, J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00271-6 · Cited by 694
Vascular inflammation and the renin-angiotensin system
Brasier, A. R., Recinos, A., & Eledrisi, M. S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000021412.56621.a2 · Cited by 586
The role of the renin-angiotensin system in the development of cardiovascular disease
Unger, T. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02321-9 · Cited by 515
Ferrario, C. M., & Strawn, W. B. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.059 · Cited by 512
Self-citationWassmann, S., Stumpf, M., Strehlow, K., Schmid, A., Schieffer, B., Böhm, M., & Nickenig, G. (2004) · Circulation Research · doi:10.1161/01.res.0000115557.25127.8d · Cited by 468
Metadata
- Authors
- Strawn, W. B., Chappell, M. C., Dean, R. H., Kivlighn, S., & Ferrario, C. M.
- Venue
- Circulation
- Published
- 2000-04-04
- Volume
- 101
- Issue
- 13
- Pages
- 1586-1593
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2114143920
- Cited by
- 270
- References
- 21
- FWCI
- 19.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of Early Atherogenesis by Losartan in Monkeys With Diet-Induced Hypercholesterolemia. https://app.cochat.ai/papers/10.1161/01.cir.101.13.1586
- The paper
- Strawn, W. B., Chappell, M. C., Dean, R. H., Kivlighn, S., & Ferrario, C. M. (2000). Inhibition of Early Atherogenesis by Losartan in Monkeys With Diet-Induced Hypercholesterolemia. Circulation. https://doi.org/10.1161/01.cir.101.13.1586
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.